| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMRA1100030 |
| P698 | PubMed publication ID | 22029983 |
| P50 | author | Peter K. Gregersen | Q7175067 |
| Judy H. Cho | Q67426077 | ||
| P2860 | cites work | Finding the missing heritability of complex diseases | Q22122198 |
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoimmune disease | Q8084905 |
| genomics | Q222046 | ||
| P304 | page(s) | 1612-1623 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Genomics and the multifactorial nature of human autoimmune disease | |
| P478 | volume | 365 |
| Q38820352 | 10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders |
| Q39804119 | A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis |
| Q57234939 | A Possible Role of Different PTPN Genes in Immune Regulation |
| Q47116537 | A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs). |
| Q40507937 | A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis |
| Q36504045 | A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease |
| Q38162671 | A peptide's perspective on antigen presentation to the immune system |
| Q44506483 | A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis. |
| Q37153818 | A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci |
| Q49838415 | Alloantigen expression on malignant cells and healthy host tissue influences graft-versus-tumor reactions after allogeneic hematopoietic stem cell transplantation |
| Q35428053 | Analysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients |
| Q34283946 | Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis. |
| Q37972803 | Anti-neutrophil cytoplasmic antibody-associated systemic vasculitis: nature or nurture? |
| Q38228454 | Antibodies specific for nucleic acids and applications in genomic detection and clinical diagnostics |
| Q38016455 | Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification |
| Q37365282 | Apoptosis in response to microbial infection induces autoreactive TH17 cells |
| Q38681632 | Association between serum/plasma adiponectin levels and immune-mediated diseases: a meta-analysis. |
| Q55092221 | Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus. |
| Q35050510 | Association of human leukocyte antigen class II with susceptibility to primary biliary cirrhosis: a systematic review and meta-analysis |
| Q90339229 | Association of serum/plasma high mobility group box 1 with autoimmune diseases: A systematic review and meta-analysis |
| Q33953893 | Association study of genes controlling IL-12-dependent IFN-γ immunity: STAT4 alleles increase risk of pulmonary tuberculosis in Morocco |
| Q92239231 | Autoantibodies in Morphea: An Update |
| Q64070262 | Autoimmune Diseases and Psychotic Disorders |
| Q35577364 | Autoimmune host-microbiota interactions at barrier sites and beyond |
| Q35568398 | Autoimmune risk loci of IL12RB2, IKZF1, XKR6, TMEM39A and CSK in Chinese patients with systemic lupus erythematosus |
| Q48722493 | Autoimmunity's next top models |
| Q37572837 | Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. |
| Q43987804 | Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder |
| Q43086838 | CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation |
| Q39271487 | Candidate genes for obesity-susceptibility show enriched association within a large genome-wide association study for BMI. |
| Q84006306 | Cell type-specific eQTLs in the human immune system |
| Q33415933 | Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome |
| Q38074354 | Clinical guidelines and definitions of autoinflammatory diseases: contrasts and comparisons with autoimmunity-a comprehensive review |
| Q34669910 | Clinical implications of copy number variations in autoimmune disorders |
| Q33837769 | Coherent somatic mutation in autoimmune disease |
| Q57307059 | Common genes in autoimmune diseases: a link between immune-mediated diseases |
| Q36192435 | Complicating autoimmune diseases in myasthenia gravis: a review |
| Q41779945 | Creatine maintains intestinal homeostasis and protects against colitis |
| Q92409140 | Crohn's Disease: Potential Drugs for Modulation of Autophagy |
| Q26782139 | Diametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunology |
| Q35132241 | Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies |
| Q38159892 | Endocrine autoimmune diseases and female infertility. |
| Q64070459 | Evaluating tofacitinib citrate in the treatment of moderate-to-severe active ulcerative colitis: design, development and positioning of therapy |
| Q33428734 | Evaluation of a DLA-79 allele associated with multiple immune-mediated diseases in dogs |
| Q34724067 | Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition |
| Q30009882 | Evidence of new risk genetic factor to systemic lupus erythematosus: the UBASH3A gene. |
| Q91803384 | FAM64A positively regulates STAT3 activity to promote Th17 differentiation and colitis-associated carcinogenesis |
| Q38179269 | Fibromyalgia and chronic widespread pain in autoimmune thyroid disease |
| Q34274496 | From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases |
| Q37416120 | Fueling autoimmunity: type I interferon in autoimmune diseases. |
| Q36593533 | GWAS implicates a role for quantitative immune traits and threshold effects in risk for human autoimmune disorders |
| Q38193918 | Gene-environment interaction in autoimmune disease |
| Q37086396 | Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways |
| Q36204561 | Genetic associations in acquired immune-mediated bone marrow failure syndromes: insights in aplastic anemia and chronic idiopathic neutropenia |
| Q37026149 | Genetics of chronic rhinosinusitis: state of the field and directions forward |
| Q34545752 | Genetics of scleroderma: implications for personalized medicine? |
| Q35921093 | Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis |
| Q97522960 | Genomic imprinting analyses identify maternal effects as a cause of phenotypic variability in type 1 diabetes and rheumatoid arthritis |
| Q36708347 | Genomic modulators of the immune response |
| Q26991570 | Genomics, personalized medicine, and pediatrics |
| Q39894355 | HLA-A*31 as a marker of genetic susceptibility to sepsis |
| Q38539811 | Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies |
| Q41185159 | High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis. |
| Q22251082 | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease |
| Q34622288 | How do autoimmune diseases cluster in families? A systematic review and meta-analysis |
| Q38554722 | Human autoimmune diseases: a comprehensive update |
| Q30852088 | Identification of possible pathogenic pathways in Behçet's disease using genome-wide association study data from two different populations |
| Q45377435 | Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene |
| Q38133018 | Immunopathogenic mechanisms of systemic autoimmune disease |
| Q34147916 | Implementation and utilization of genetic testing in personalized medicine |
| Q37460609 | Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility |
| Q52714937 | In-patient outcomes of Hematopoietic Stem Cell Transplantation in Patients with Immune Mediated Inflammatory Diseases: A Nationwide Study. |
| Q37549953 | Influence of sex differences on microRNA gene regulation in disease |
| Q52641247 | Innate lymphoid cells in autoimmunity and chronic inflammatory diseases. |
| Q28066488 | Intestinal Microbiota as an Alternative Therapeutic Target for Epilepsy |
| Q37260460 | Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report. |
| Q57655181 | Investigation of selected cytokine genes suggests thatIL2RAand theTNF/LTAlocus are risk factors for severe alopecia areata |
| Q36404704 | JAK and STAT signaling molecules in immunoregulation and immune-mediated disease |
| Q38761142 | JAK inhibition in inflammatory bowel disease |
| Q34321767 | JAKs and STATs in immunity, immunodeficiency, and cancer |
| Q36907640 | KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor |
| Q37381383 | LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity |
| Q36727669 | Lack of association between the protein tyrosine phosphatase non-receptor type 22 R263Q and R620W functional genetic variants and endogenous non-anterior uveitis |
| Q33678499 | Lack of association of C3 gene with uveitis: additional insights into the genetic profile of uveitis regarding complement pathway genes |
| Q37058776 | Latest advances in connective tissue disorders |
| Q41916915 | Lentiviral Mediating Genetic Engineered Mesenchymal Stem Cells for Releasing IL-27 as a Gene Therapy Approach for Autoimmune Diseases |
| Q35532322 | Loss of anergic B cells in prediabetic and new-onset type 1 diabetic patients. |
| Q36905584 | Mechanistic biomarkers for clinical decision making in rheumatic diseases |
| Q37282406 | New insight on the Xq28 association with systemic sclerosis |
| Q35060133 | No evidence of association between common autoimmunity STAT4 and IL23R risk polymorphisms and non-anterior uveitis. |
| Q38263875 | Noise in multiple sclerosis: unwanted and necessary |
| Q28730714 | Novel associations for hypothyroidism include known autoimmune risk loci |
| Q40253467 | Novel insights into systemic autoimmune rheumatic diseases using shared molecular signatures and an integrative analysis |
| Q36221861 | Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity. |
| Q36063925 | Origin of B-Cell Neoplasms in Autoimmune Disease |
| Q38655324 | Oxindole-based SYK and JAK3 dual inhibitors for rheumatoid arthritis: designing, synthesis and biological evaluation |
| Q38077588 | Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals |
| Q52311683 | Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides. |
| Q30655444 | Pathological implications of Th1/Th2 cytokine genetic variants in Behçet's disease: Data from a pilot study in a Sicilian population. |
| Q38917824 | Periodontal disease and women's health |
| Q36100091 | Phenome-Wide Association Study to Explore Relationships between Immune System Related Genetic Loci and Complex Traits and Diseases |
| Q33956662 | Pivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis |
| Q38371604 | Proteome dynamics in biobanked horse peripheral blood derived lymphocytes (PBL) with induced autoimmune uveitis. |
| Q34198746 | Rasmussen encephalitis and comorbid autoimmune diseases: A window into disease mechanism? |
| Q57928820 | Relationships among Antibodies against Extractable Nuclear Antigens, Antinuclear Antibodies, and Autoimmune Diseases in a Brazilian Public Hospital |
| Q37998396 | Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells |
| Q45126922 | Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients |
| Q38331233 | Rheumatic symptoms in autoimmune thyroiditis |
| Q28943379 | Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08 |
| Q36430775 | Rituximab does not reset defective early B cell tolerance checkpoints |
| Q26829755 | Role of viruses and bacteria-virus interactions in autoimmunity |
| Q64235416 | SLE: reconciling heterogeneity |
| Q37622868 | Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells |
| Q28084677 | Solving the puzzle of autoimmunity: critical questions |
| Q36890946 | Specific peripheral B cell tolerance defects in patients with multiple sclerosis |
| Q30399603 | Structural Evaluation and Binding Mode Analysis of CCL19 and CCR7 Proteins-Identification of Novel Leads for Rheumatic and Autoimmune Diseases: An Insilico study |
| Q91711905 | Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders |
| Q46264402 | T Cell-Mediated Chronic Inflammatory Diseases Are Candidates for Therapeutic Tolerance Induction with Heat Shock Proteins |
| Q41161406 | Th17 in Animal Models of Rheumatoid Arthritis |
| Q26747427 | The Autoimmune Ecology |
| Q57490878 | The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit? |
| Q56452307 | The Multiple Autoimmune Syndromes. A Clue for the Autoimmune Tautology |
| Q36385156 | The association between genetic polymorphisms of the interleukin-23 receptor gene and susceptibility to uveitis: a meta-analysis |
| Q37965346 | The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease |
| Q64099722 | The emerging role of epigenetics in human autoimmune disorders |
| Q36918205 | The genetics of scleroderma: looking into the postgenomic era |
| Q36490256 | Therapeutic targeting of the inflammome |
| Q34651167 | Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and Th17 T-helper cell subsets and is a direct STAT target gene |
| Q35134186 | Unifying immunology with informatics and multiscale biology. |
| Q28388501 | Unknown quantity: regulating radionuclides in tap water |
| Q34030650 | Update on Janus kinase antagonists in inflammatory bowel disease |
| Q36127459 | Urine metabolome profiling of immune-mediated inflammatory diseases |
| Q37961446 | Viruses and vitamin D in the etiology of type 1 diabetes mellitus and multiple sclerosis |
| Q35012569 | What is next after the genes for autoimmunity? |
Search more.